Laparoscopic Heller Cardiomyotomy and Dor Fundoplication for Esophageal Achalasia Possible Factors Predicting Outcome

Total Page:16

File Type:pdf, Size:1020Kb

Laparoscopic Heller Cardiomyotomy and Dor Fundoplication for Esophageal Achalasia Possible Factors Predicting Outcome ORIGINAL ARTICLE Laparoscopic Heller Cardiomyotomy and Dor Fundoplication for Esophageal Achalasia Possible Factors Predicting Outcome George Pechlivanides, MD, PhD; Emmanuel Chrysos, MD, PhD; Elias Athanasakis, MD; John Tsiaoussis, MD, PhD; John Sophocles Vassilakis, MD, PhD; Evaghelos Xynos, MD, PhD, FACS Hypothesis: Laparoscopic Heller myotomy with ante- stage II, 12 had stage III, and 4 had stage IV at preop- rior hemifundoplication is the surgical procedure of choice erative radiologic examination. At surgery, there were for the treatment of esophageal achalasia. Specific fac- no conversions to open procedures, and 2 mucosal per- tors, eg, severity of esophageal body deformity, might forations were immediately identified and sutured. affect postoperative outcome. Good or excellent results were seen in 26 patients. All patients with stage I or II disease had excellent func- Design: Prospective case-control study. tional results. Of patients with stage III disease, results were excellent in 7, good in 4, and bad in 1. Of patients Setting: Academic referral center for gastrointestinal tract with stage IV disease, 2 had good results and 2 had bad motility disorders. results. After surgery, lower esophageal sphincter pres- sure was reduced significantly (from 46.1±12.1 to Patients: Twenty-nine patients with esophageal acha- 5.4±1.8 mm Hg; PϽ.001), as was esophageal diameter lasia who underwent 1 to 3 sessions of failed pneumatic (from 61±17 to 35±19 mm; PϽ.001) (data are given as dilation each. mean±SD). However, an excellent result occurred only in patients with a postoperative esophageal diameter Intervention: Laparoscopic Heller myotomy with an- less than 40 mm. terior (Dor) hemifundoplication. Conclusion: Functional outcome of laparoscopic Heller- Main Outcome Measures: Preoperative and postop- Dor procedure for achalasia is related to the preopera- erative symptomatic evaluation, esophagoscopy, esopha- tive stage of the disease on the esophagogram and to the gography, stationary and ambulatory esophageal ma- extent of reduction in esophageal width after surgery. nometry, and pH monitoring. Results: Three patients had stage I disease, 10 had Arch Surg. 2001;136:1240-1243 HEN pneumatic dila- scopic approach is associated with signifi- tion of the lower cantly less blood loss, parenteral narcotic esophageal sphinc- use, hospitalization time, and time off ter (LES) is contra- work.7,8 However, little has been reported indicated or poor re- about any predictors of outcome after sur- Wsults are anticipated or the procedure fails gery. It has been suggested that a signifi- to relieve the patient’s symptoms, surgery cant reduction in esophageal body diam- should be considered for the treatment of eter on an esophagogram after surgery is esophageal achalasia.1-4 Transabdominal car- associated with good postoperative func- diomyotomy, first described by Heller in tional results, whereas the patient with a 1914,5 offers satisfactory results in approxi- dilated and tortuous esophagus is un- mately 95% of patients with achalasia.6 likely to respond to cardiomyotomy.9 More recently, minimally invasive In the present study, we analyzed esophagomyotomy by laparoscopy is re- data from 29 patients who underwent placing open surgery for achalasia, but data laparoscopic Heller myotomy and ante- comparing these 2 different approaches are rior hemifundoplication for achalasia and From the Laboratory of 7 Gastrointestinal Motility and sparse. Data from small series show simi- who completed 1-year follow-up. Empha- the Department of General lar results concerning relief of dysphagia sis was given to documentation of the Surgery, University Hospital of and satisfaction of the patient with the out- results and to definition of any predictors Heraklion, Crete, Greece. come after either approach. The laparo- of outcome. (REPRINTED) ARCH SURG/ VOL 136, NOV 2001 WWW.ARCHSURG.COM 1240 ©2001 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 10/02/2021 PATIENTS AND METHODS instilling 50 mL of diluted methylene blue through a nasal tube into the esophageal lumen. The operation was com- pleted with an anterior hemifundoplication of the Dor type, Between January 1, 1995, and June 30, 1998, 29 patients un- which was accomplished by suturing the anterior gastric fun- derwent laparoscopic treatment for esophageal achalasia. Pre- dus first to the left cut edge of the myotomy and the left pil- operative workup included clinical assessment, esophagog- lar of the crus and then to the right cut edge of the my- raphy, upper alimentary endoscopy, esophageal manometry, otomy and the right pillar of the crus.12 24-hour ambulatory esophageal manometry, and pH moni- The nasogastric tube was left in place for 24 to 48 hours toring. Severity of dysphagia, regurgitation, and heartburn was and was removed after a meglumine diatrizoate (Gastro- assessed separately according to a scoring system similar to grafin) swallow showed easy passage through the lumen of that described by Johnson and DeMeester10 (0 indicates ab- the gastroesophageal junction and no leaks. A liquid diet was sence; 1, occasional episodes; 2, frequent episodes; and 3, daily then resumed. On the second postoperative day and con- episodes). On the esophagogram, the diameter of the esopha- tinuing for 6 to 8 weeks, a soft diet was recommended. Un- gus 8 cm proximal to the gastroesophageal junction was mea- less other complications occurred, patients were discharged sured and the disease was graded as follows: stage I, diameter from the hospital on the second to third postoperative day. less than 40 mm; stage II, diameter of 40 to 60 mm; stage III, diameter greater than 60 mm; and stage IV, diameter of any POSTOPERATIVE ASSESSMENT size with sigmoid configuration of the distal esophagus. Am- bulatory esophageal manometric and pH monitoring data were Patients were clinically assessed 2 weeks, 3 months, and 1 assessed according to standard definitions.11 year after surgery. Clinical outcome was classified as ex- cellent (symptomatic score of 0-1), good/satisfactory (symp- OPERATIVE TECHNIQUE AND tomatic score of 2-4), or bad (symptomatic score of Ն5). POSTOPERATIVE MANAGEMENT Nine months to 1 year after surgery, all patients under- went esophagography, standard stationary manometry, and Dissection was limited to the anterior aspect of the abdomi- 24-hour ambulatory esophageal pH monitoring. nal esophagus and the diaphragmatic crura. The anterior va- gal trunk was dissected and preserved, as was the hepatic STATISTICAL ANALYSIS branch of the anterior vagus. After dissecting and excising the fatty pad of the gastroesophageal junction, the my- Unless otherwise stated, all values are expressed as otomy was started from the junction and was extended proxi- mean±SD. Comparisons between preoperative and post- mally on the esophagus up to 5 cm by dividing the circular operative values of the various variables were made by ap- muscular layer and distally on the stomach up to 1.0 to 1.5 plying the Mann-Whitney test for paired values and the ␹2 cm by dividing the oblique muscular fibers. Division of the test with the Yates correction, as appropriate. Regression muscular fibers was achieved using a hook device and mini- analysis was also used to identify any correlation between mal electrocautery. The cut muscular edges were dissected the preoperative stage of the disease and the clinical and laterally to fully expose the anterior aspect of the submu- laboratory outcomes after surgery. PϽ.05 was considered cosa. The integrity of the submucosal layer was tested by statistically significant. RESULTS incomplete in 6. At standard esophageal manometry, esophageal peristalsis was absent in all patients. Ambu- PREOPERATIVE ASSESSMENT latory manometry showed aperistalsis in 26 patients, failed peristalsis in 2, and dropped peristalsis in 1. An abnor- There were 12 men and 17 women aged 47.5±18.9 years mal DeMeester score (51±22) on esophageal pH moni- (range, 18-74 years). Duration of symptoms was 5.2±4.5 toring was found in 9 patients, 7 of whom reported heart- years (range, 1-19 years). Twelve patients underwent 1 ses- burn. In these 9 patients, the pattern of reflux was sion, 10 underwent 2 sessions, and 4 underwent 3 ses- characterized by a few long-duration reflux episodes (total sions of LES pneumatic dilation before surgery, with tem- reflux time, 18%±7%), with a pH just less than 4. porary or no relief of dysphagia. In only 3 patients with stage IV disease on esophagography (dilated sigmoid shape OPERATIVE AND POSTOPERATIVE COURSE of the distal esophagus) was pneumatic dilation not at- tempted immediately before surgery, although they had Operative time was 73±18 minutes (range, 45-105 1 to 2 attempts at earlier stages of disease. All patients had minutes). Blood loss was minimal. The location of the constant dysphagia and regurgitation. Twelve patients re- gastroesophageal junction with use of the endoscope as ported weight loss, 10 experienced recurrent respiratory the Z-line was usually 0.5 to 1.0 cm more proximal than tract symptoms, and 7 had heartburn. Two young pa- that found using the laparoscope as the proximal border tients reported spontaneous or postdeglutition chest pain. of the oblique muscle fibers of the stomach. In most According to the preoperative esophagogram, pa- patients, there was considerable difficulty in detaching tients were classified as follows: stage I, 3 patients; stage the cut edges of the circular muscle fibers away from the II, 10; stage III, 12; and stage IV, 4. Mean esophageal di- underlying esophageal submucosa. Two intraoperative ameter was 61±17 mm. Mean LES pressure was mucosal perforations occurred, both at the level of the 46.1±12.1 mm Hg (range, 29-69 mm Hg). Lower esoph- gastroesophageal junction: one using the transesopha- ageal sphincter relaxation was absent in 23 patients and geal endoscope and the other using the hook device dur- (REPRINTED) ARCH SURG/ VOL 136, NOV 2001 WWW.ARCHSURG.COM 1241 ©2001 American Medical Association. All rights reserved.
Recommended publications
  • Lenox Hill Hospital Department of Surgery Advanced Laparoscopic Surgery Goals and Objectives
    Lenox Hill Hospital Department of Surgery Advanced Laparoscopic Surgery Goals and Objectives Medical Knowledge and Patient Care: Residents must demonstrate knowledge and application of the pathophysiology and epidemiology of the diseases listed below for this rotation, with the pertinent clinical and laboratory findings, differential diagnosis and therapeutic options including preventive measures, and procedural knowledge. They must show that they are able to gather accurate and relevant information using medical interviewing, physical examination, appropriate diagnostic workup, and use of information technology. They must be able to synthesize and apply information in the clinical setting to make informed recommendations about preventive, diagnostic and therapeutic options, based on clinical judgement, scientific evidence, and patient preferences. They should be able to prescribe, perform, and interpret surgical procedures listed below for this rotation. All residents are expected to finish the laparoscopy curriculum. Upon completion of the curriculum, the resident will be able to: • Describe the instruments and equipment used in laparoscopic surgery • Identify important intraoperative considerations such as anesthesia and patient positioning • Discuss the physiology of the pneumoperitoneum • Outline the process of access, trocar placement and abdominal examination • Demonstrate the technique of laparoscopic skills, including cutting, dissection and suturing • Provide an overview of biopsy techniques and hemostasis • Summarize the process of exiting the abdomen and the requirements for postoperative care The curriculum consists of two major components: 1. Didactic component: This includes two comprehensive, CD-ROM based educational modules- Fundamentals of Laparoscopic Surgery (FLS) and Laparoscopy 101. These self-study guides cover a wide range of topics including techniques for safe entry into the peritoneal cavity, physiological changes associated with pneumoperitoneum, appropriate use of energy sources and postoperative complications and care.
    [Show full text]
  • Tailoring Therapy for Achalasia
    Tailoring Therapy for Achalasia Joel E. Richter, MD Dr Richter is a professor of medicine, Abstract: Achalasia is a rare esophageal motility disorder with Hugh F. Culverhouse Chair for impaired lower esophageal sphincter (LES) opening and aperi- Esophageal Disorders, director of stalsis. The disease cannot be cured and aperistalsis cannot be the Division of Digestive Diseases corrected, but good long-term symptom relief results from some and Nutrition, and director of the Joy McCann Culverhouse Center for degree of destruction to the obstruction of the LES. The presence Esophageal and Swallowing Disorders of multiple treatment options with excellent scientific efficacy now at the University of South Florida offers the opportunity to tailor therapy for patients with achalasia. Morsani College of Medicine in Drug therapy, especially botulinum toxin A, should be reserved Tampa, Florida. for elderly patients with short life expectancy. Pneumatic dilation and surgical myotomy are equally effective for patients with types Address correspondence to: I and II achalasia. Pneumatic dilation offers a less morbid, cheaper Dr Joel E. Richter outpatient procedure, especially for older patients and women, University of South Florida but redilation may be needed. Surgical myotomy is effective across Morsani College of Medicine all groups, especially young men. Laparoscopic Heller myotomy 12901 Bruce B. Downs Blvd, MDC 72 with fundoplication is preferred in patients with megaesophagus, Tampa, FL 33612 diverticulum, or hiatal hernia. Peroral endoscopic myotomy is the Tel: 813-625-3992 Fax: 813-905-9863 treatment of choice for patients with type III achalasia, but requires E-mail: [email protected] advanced endoscopic skills, and the risk of gastroesophageal reflux disease is high.
    [Show full text]
  • Short Paper Session 6.2 11:30 - 13:00 Thursday, 6Th May, 2021 Presentation Type Short Paper Presentations Dimitris Damaskos, Brian Dobbins
    Short Paper Session 6.2 11:30 - 13:00 Thursday, 6th May, 2021 Presentation type Short Paper Presentations Dimitris Damaskos, Brian Dobbins TP6.2.1 Does the use of Negative Pressure Wound Dressings decrease superficial Surgical Site Infections in the Emergency Laparotomy? Eleanor Smith1,2, Hannah Merriman1, Safia Haidar1, Grace Knudsen1, Victoria Kinkaid1, Sarah Burton1 1Frimley Park Hospital. 2University Hospital Lewisham Abstract AIMS: Surgical site infection (SSI) can be a significant cause of morbidity in the emergency laparotomy patient. Previous research into the role of negative pressure wound dressings to improve the rate of SSI culminated with NICE guidelines in 2019 recommending the use of negative pressure wound dressings in people who would be considered high risk for developing an SSI. Based on this guideline, we changed our policy to recommend the use of PICO dressings for all emergency laparotomies in order to decrease our rate of SSI. Our aim of this study was to assess the success of this policy change. METHODS: In this closed-loop audit we analysed data from all laparotomy patients at Frimley Park Hospital over 12 months. We retrospectively analysed the data of the pre-intervention group between January – June 2019, and prospectively audited all laparotomy patients between July – December 2019. RESULTS: We found that there was no significant decrease in the rate of superficial SSI, from a pre intervention rate of 22.2% to a post intervention 24.1%. Similarly, we found no significant decrease in the rate of wound dehiscence, which increased from 13.8% to 17.7%. In further assessment we saw no significant difference in the rates of contamination, ASA grades, or closure techniques to account for these increased rates.
    [Show full text]
  • Selecthealth Medical Policies Gastroenterology Policies
    SelectHealth Medical Policies Gastroenterology Policies Table of Contents Policy Title Policy Last Number Revised Bravo PH Monitoring Probe 200 12/19/09 Colonic Manometry 619 10/02/17 Computed Tomography Colonography (CTC) Virtual Colonoscopy 399 04/22/10 DNA Analysis of Stool for Colon Cancer Screening (Cologuard) 260 09/16/21 Drug Monitoring in Inflammatory Bowel Disease 532 02/26/20 Endoscopic Ultrasonography (EUS) 118 05/31/16 Formulas And Other Enteral Nutrition 534 12/21/20 Gastric Pacing/Gastric Electrical Stimulation (GES) 585 05/27/20 Genetic Testing: CA 19-9 Testing 331 06/30/16 IB-Stim 637 10/14/19 Injectable Bulking Agents In The Treatment Of Fecal Incontinence 531 06/10/15 In-Vivo Detection of Mucosal Lesions with Endoscopy 574 10/15/15 LINX System For The Management of Gerd 520 01/28/13 Peroral Endoscopic Myotomy (POEM) for the Treatment of 588 06/06/16 Esophageal Achlasia Pillcam ESO (Esophagus) 278 08/18/08 Prognostic Serogenetic Testing for Crohn’s Disease (Prometheus® Monitr™) 484 04/06/21 Serologic Testing For Diagnosis of Inflammatory Bowel Disease 175 04/06/21 Serum Testing For Hepatic Fibrosis (Fibrospect II, The Fibrotest, and The 274 08/28/20 HCV-Fibrosure Test) Transcutaneous Electrical Stimulation Devices For Nausea and Vomiting 199 12/27/09 Transendoscopic Anti-Reflux Procedures 198 08/06/10 By accessing and/or downloading SelectHealth policies, you automatically agree to the Medical and Coding/ Reimbursement Policy Manual Terms and Conditions. Gastroenterology Policies, Continued MEDICAL POLICY BRAVO PH MONITORING PROBE Policy # 200 Implementation Date: 10/10/03 Review Dates: 11/18/04, 9/7/05, 12/21/06, 12/20/07, 12/18/08, 12/16/10, 12/15/11, 4/12/12, 6/20/13, 4/17/14, 5/7/15, 4/14/16, 4/27/17, 6/24/18, 4/23/19, 4/6/20 Revision Dates: 12/19/09 Disclaimer: 1.
    [Show full text]
  • Treatment of Achalasia: Lessons Learned with Chagas' Disease
    Diseases of the Esophagus (2008) 21, 461–467 DOI: 10.1111/j.1442-2050.2008.00811.x Original article Treatment of achalasia: lessons learned with Chagas’ disease F. A. M. Herbella,1 J. L. B. Aquino,2 S. Stefani-Nakano,3 E. L. A. Artifon,4 P. Sakai,4 E. Crema,5 N. A. Andreollo,6 L. R. Lopes,6 C. de Castro Pochini,7 P. R. Corsi,7 D. Gagliardi,7 J. C. Del Grande1 1Department of Surgery, Division of Esophagus and Stomach, Federal University of Sao Paulo, Sao Paulo; 2Department of Surgery, School of Medicine, Catholic University, Campinas; 3Santa Casa de Goiânia, Goiania; 4Department of Surgery, Gastrointestinal Endoscopy Unit, University of Sao Paulo Medical School, Sao Paulo; 5Department of Surgery, Universidade Federal do Triângulo Mineiro, Uberaba, MG; 6Department of Surgery, Division of Esophagus and Stomach and Gastrocentro, State University of Campinas, Campinas; 7Department of Surgery, Santa Casa de Sao Paulo Medical School, Sao Paulo, Brazil SUMMARY. Chagas’ disease (CD) is highly prevalent in South America. Brazilian surgeons and gastroenter- ologists gained valuable experience in the treatment of CD esophagopathy (chagasic achalasia) due to the high number of cases treated. The authors reviewed the lessons learned with the treatment of achalasia by different centers experienced in the treatment of Chagas’ disease. Preoperative evaluation, endoscopic treatment (forceful dilatation and botulinum toxin injection), Heller’s myotomy, esophagectomy, conservative techniques other than myotomy, and reoperations are discussed in the light of personal experiences and review of International and Brazilian literature. Aspects not frequently adopted by North American and European surgeons are emphasized.
    [Show full text]
  • Subject Index
    Subject Index – reconstruction 475 – para-aortic lymph node removal 58 A – resection – reconstruction 61 ––access567 Caroli syndrome 339 abdominothoracic en bloc esophagectomy – – bilioenteric anastomosis 575 catheter 41 with high intrathoracic anastomosis – – caudate lobe 571, 577 cavo-cavostomy – contraindications 89 – – clinical evaluation 56 – end-to-side 471 – indications 89 – – complications 582 – side-to-side 471 access 5 – – connective tissue dissection 567 central pancreatectomy 781, 783 – esophageal surgery 14 – – contraindications 565 cervical esophagectomy 47 – establishing pneumoperitoneum 16 – – demarcation of the liver capsule 578 – contraindications 47 – incision 10 ––distal568 – esophagojejunal anastomosis 53 ––cervical14 – – endoscopy 566 – indications 47 ––bilateral subcostal13 – – hepatic artery 570, 576 – postoperative complications 54 ––J-shaped13 ––hepatic duct565 –preparation – – midline 10 – – indications 565 – – of the cervical region 49 – – subcostal 12 – – intrahepatic 573, 580 – – of the jejunal loop 51 – laparoscopic surgery 16 – – Kocher maneuver 568 – vascular anastomosis 52 –thoracotomy14 – – laboratory tests 566 cervical lymphadenectomy 103 – upper midline laparotomy 14 – – left hepatic resection 570 cholangiocarcinoma 339 – veress needle 16 ––left portal vein570 cholangiography 528, 542 – with the open technique 17 – – liver capsule 572 cholecystectomy 525 achalasia 139 – – lymph node dissection 567, 581 – laparoscopy 527 – Dor fundoplication 141 ––pericaval segment572 – open 527 – Heller myotomy 140
    [Show full text]
  • Guide for Answering Theory Questions in MS Surgery
    WBUHS (2011-2015) MS- PAPER – I -IV Guide for Answering theory questions in MS Surgery Dr. Arkaprovo Roy ASSOCIATE PROFESSOR DEPARTMENT OF GENERAL SURGERY Dr. Arkaprovo Roy ASSOCIATE PROFESSOR DEPARTMENT OF GENERAL SURGERY MEDICAL COLLEGE AND HOSPITAL, KOLKATA THE WEST BENGAL UNIVERSITY OF HEALTH SCIENCES MS (General Surgery) Examination, 2015 PAPER I Time Allowed: 3 Hours Full Marks: 100 Attempt all questions 1. How will you assess the nutritional status of a surgical patient? Define and classify artificial nutritional support (ANS). Give an account of enteral nutrition and its advantages and drawbacks. 4+4+8+4 2. Describe the lymph node status in relation to spread of carcinoma stomach. Discuss in detail the different types of gastric carcinoma and prognosis in respect to lymph node harvest. 5+10+5 3. Write short notes of the following: 5x6 a) Pharmacological therapy in patients awaiting surgery for pheochromocytoma. b) Retroperitoneal fibrosis. c) Ethics and law in surgical practice. d) Pathophysiology of short bowel syndrome. e) Metabolic response to trauma. 4. Answer briefly on the following. 4x71/2 a) Laparoscopic versus conventional surgery in pregnancy. b) Component separation and role of blood components in surgery. c) Graft rejection in transplants. d) Immunohistochemistry. THE WEST BENGAL UNIVERSITY OF HEALTH SCIENCES MS (General Surgery) Examination, 2015 April 2015 PAPER I Time Allowed: 3 Hours Full Marks: 100 Attempt all questions 1. How will you assess the nutritional status of a surgical patient? Define and classify artificial nutritional support (ANS). Give an account of enteral nutrition and its advantages and drawbacks. 4+4+8+4 Answer.
    [Show full text]
  • Recent Advances in Third-Space Endoscopy
    Recent Advances in Third-Space Endoscopy Zaheer Nabi, MD, DNB, D. Nageshwar Reddy, MD, DM, and Mohan Ramchandani, MD, DM Dr Nabi and Dr Ramchandani are Abstract: The capabilities of interventional gastrointestinal endos- consultant gastroenterologists and Dr copy have significantly increased over the past several decades. Reddy is chairman and chief gastro- Improvements in devices and techniques have eased the transfer enterologist at the Asian Institute of of novel concepts from bench to bedside. The concept of submu- Gastroenterology in Hyderabad, India. cosal endoscopy with mucosal flap safety valve has enabled endos- copists to securely use submucosal space, or third space. Peroral Address correspondence to: endoscopic myotomy was the initial procedure performed utilizing Dr D. Nageshwar Reddy submucosal space in patients with achalasia. Subsequently, this Asian Institute of Gastroenterology technique has been used successfully for removal of subepithelial 6-3-661, Somajiguda tumors from the esophagus and the stomach. All third-space endos- Hyderabad - 500 082 India copy procedures use a similar technique—a submucosal tunnel Tel: +91-40-2337-8888 is created, and then a myotomy is performed or a sub epithelial Fax: +91-40-2332-4255 tumor is dissected away from the initial site of the mucosal E-mail: [email protected] incision. The other potential indications for third-space endos- copy include refractory gastroparesis, Zenker diverticulum, and restoration of completely obstructed esophageal lumen. Although the emerging data look promising for peroral endoscopic myotomy and pyloromyotomy, randomized studies with long-term follow-up are lacking. Submucosal endoscopy is largely safe, and the occur- rence of major adverse events is uncommon.
    [Show full text]
  • Robot-Assisted Laparoscopic Heller Myotomy Using the Davinci Xi
    4 Review Article Page 1 of 4 Robot-assisted laparoscopic heller myotomy using the DaVinci Xi David S. Demos, William B. Tisol Aurora St. Luke’s Medical Center, Milwaukee, Wisconsin, USA Contributions: (I) Conception and design: All authors; (II) Administrative support: All authors; (III) Provision of study materials or patients: All authors; (IV) Collection and assembly of data: All authors; (V) Data analysis and interpretation: All authors; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: David S. Demos, MD. Aurora St. Luke’s Medical Center, 2901 W. Kinnickinnic River Pkwy, Professional Office Bldg 1, Suite 507, Milwaukee, Wisconsin, USA. Email: [email protected]. Abstract: Definitive therapy for achalasia remains an esophageal myotomy across the gastroesophageal junction (GEJ). Approaches to myotomy include transthoracic and transabdominal techniques, both open and minimally invasive. Advantages of a transabdominal approach include full access to the stomach below the GEJ for complete myotomy, the angle of approach to the myotomy, and fundoplication. The use of the Da Vinci Xi surgical robot (Intuitive Surgical, Sunnyvale, CA, USA) adds some distinct advantages to the laparoscopic approach. These include: (I) a steady camera with high-definition, three-dimensional view of the circumferential muscle fibers, (II) tremor reduction through the robotic console, (III) wristed instruments providing flexibility in angle of approach and dexterity, and (IV) bi-polar energy use for more delicate, precise fiber division without excessive thermal spread. The advantage of bi-polar energy delivery over monopolar cautery cannot be overstated. We describe our approach to DaVinci Xi Robot-assisted laparoscopic modified heller myotomy with anterior partial fundoplication.
    [Show full text]
  • Upper Endoscopy for Gastroesophageal Reflux Disease & Upper Gastrointestinal Symptoms
    Upper Endoscopy for Gastroesophageal Reflux Disease & Upper Gastrointestinal Symptoms Health Technology Assessment Program FINAL EVIDENCE REPORT Appendices April 12, 2012 Health Technology Assessment Program (HTA) http://hta.hca.wa.gov Washington State Health Care Authority [email protected] PO Box 42712 (360) 725-5126 Olympia, WA 98504-2712 Washington State Health Care Authority Health Technology Assessment Program Upper Endoscopy for Gastroesophageal Reflux Disease (GERD) and Upper Gastrointestinal (GI) Symptoms - Appendices April 2012 Center for Evidence-based Policy Oregon Health & Science University 3455 SW US Veterans Hospital Road Mailstop SN-4N, Portland, OR 97239-2941 Phone: 503.494.2182 Fax: 503.494.3807 http://www.ohsu.edu/ohsuedu/research/policycenter/med/index.cfm Washington State Health Care Authority Health Technology Assessment Program Appendix A. MEDLINE® Search Strategy Database: Ovid MEDLINE(R) and Ovid OLDMEDLINE(R) <1946 to February Week 1 2012> Search Strategy: -------------------------------------------------------------------------------- 1 exp Endoscopy/ (226579) 2 exp Endoscopes/ (19136) 3 1 or 2 (235467) 4 (endoscop$ or gastroscop$ or esophagoscop$ or duodenoscop$).mp. [mp=title, abstract, original title, name of substance word, subject heading word, protocol supplementary concept, rare disease supplementary concept, unique identifier] (153420) 5 3 or 4 (279025) 6 exp Stomach Diseases/di (18998) 7 exp Esophageal Diseases/di (18094) 8 exp Duodenal Diseases/di (8222) 9 exp Upper Gastrointestinal Tract/ (160060) 10 exp diagnosis/ (5821301) 11 di.fs. (1767793) 12 10 or 11 (6464793) 13 9 and 12 (67560) 14 6 or 7 or 8 or 13 (97729) 15 exp "signs and symptoms, digestive"/ (115435) 16 14 and 15 (4556) 17 5 and 16 (1880) 18 (dyspep$ or heartburn$ or ((upset$ or sore$ or ache$ or pain$ or complain$ or symptom$ or bother$) adj5 (stomach$ or esophag$ or belly))).mp.
    [Show full text]
  • Tailored Per-Oral Endoscopic Esophageal Myotomy
    SAGES Research Grant: Tailored Per-Oral Endoscopic Esophageal Myotomy Based on 5 years Esophageal Function Testing for Achalasia Results in Identifying Predictors of Post-operative GERD or Recurrent Achalasia. PI: Kristin Beard, MD2, Co-Investigators: Ahmed M. Sharata MD1, Paul D. Colavita MD2, Ezra Teitelbaum MD2, Christy M. Dunst MD 1,2,3; Kevin Reavis MD 1,2,3, Lee L. Swanström MD.1,2,3 1. Foundation for Surgical Innovation and Education 2. Oregon Clinic GMIS Division 3. Providence Portland Medical Center Contact: 4805 Northeast Glisan Street, Suite 6N50, Portland, OR, 97213 USA (503) 281-0561 Statement of Funding: There is no other pending or on hand funding for this project. Duration of Project: 12 months SUMMARY: Introduction: Achalasia is an acquired, progressive esophageal motility disorder of failed esophagogastric junction (EGJ) relaxation and failed peristalsis of the esophageal body that is surgically treatable with myotomy. Per oral endoscopic myotomy (POEM) is a minimally invasive technique first performed clinically in 2008 which allows a completely endoscopic myotomy that can be tailored specifically to each patient. This technique has now been utilized in hundreds of patients worldwide, and in over 100 patients at our center. However, long term outcomes data for patients treated with POEM are lacking given its recent development. Studies thus far have shown safety and efficacy of the procedure, but have also identified a considerable rate of postoperative GERD, which is not reliably symptomatic and may go undiagnosed without routine scheduled testing. We mandate periodic objective testing for postoperative POEM patients for this reason. Impedance planimetry measurement with a trans-orally inserted functional lumen-imaging probe (EndoFLIP) technology allows effective, on the spot distensibility measurement of the esophageal lumen during endoscopy.
    [Show full text]
  • Achalasia: Incidence, Prevalence and Survival. a Populationbased Study
    Neurogastroenterol Motil (2010) 22, e256–e261 doi: 10.1111/j.1365-2982.2010.01511.x Achalasia: incidence, prevalence and survival. A population-based study D. C. SADOWSKI,* F. ACKAH , B. JIANGà &L.W.SVENSON§,– *GI Motility Laboratory, Royal Alexandra Hospital, University of Alberta, Edmonton, AB, Canada Alberta Ministry of Health and Wellness, Provincial Government of Alberta, Edmonton, AB, Canada àDepartment of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI, USA §Alberta Ministry of Health and Wellness, Provincial Government of Alberta; Department of Public Health Sciences, School of Public Health, University of Alberta, AB, Canada –Department of Community Health Sciences, University of Calgary, Edmonton, AB, Canada Abstract 10.82/100 000 in 2007. Survival of achalasia cases was Background Studies of achalasia epidemiology are significantly less than age–sex matched population important as they often yield new insights into disease controls (P < 0.0001). Conclusions & Inferences Using etiology. In this study, our objective was to carry out a population-based approach, the incidence and prev- the first North American population-based study of alence of treated achalasia is 1.63/100 000 and 10.82/ achalasia epidemiology using a governmental admin- 100 000, respectively. The disease appears to have a istrative database. Methods All residents in the prov- stable incidence but a rising prevalence. Survival of ince of Alberta, Canada receive universal healthcare achalasia cases is significantly less than age-matched coverage as a benefit. The provincial health ministry, healthy controls. Alberta Health and Wellness, maintains a central Keywords achalasia, epidemiology. stakeholder database of patient demographic infor- mation and physician billing claims.
    [Show full text]